Evidence map›Paper›PMID 28297579›Full record

ArticleStem cells translational medicine2017

Endothelial Cells Promote Expansion of Long-Term Engrafting Marrow Hematopoietic Stem and Progenitor Cells in Primates.

Jennifer L Gori, Jason M Butler, Balvir Kunar, Michael G Poulos, Michael Ginsberg, Daniel J Nolan, Zachary K Norgaard, Jennifer E Adair, Shahin Rafii, Hans-Peter Kiem

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Stem cells translational medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04057833 (A Phase 1 Open-Label, Single-Center Investigator Initiated Trial), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04057833 phase1active not recruitingnot on this mapstarted 2019, after this paper: background citation

A Phase 1 Open-Label, Single-Center Investigator Initiated Trial (IIT) of E-CEL UVEC Cells as an Adjunct Cell Therapy for the Arthroscopic Rotator Cuff Repair in Adults

TypeinterventionalSponsorHospital for Special Surgery, New YorkRan2019 to 2026Enrolled20ConditionsRotator Cuff Tears, Muscle Atrophy or Weakness, Tendon Rupture - Shoulder, Safety IssuesArmsE-CEL UVEC
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jennifer L GoriClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Jason M ButlerHoward Hughes Medical Institute, Chevy Chase, Maryland, USA.
Balvir KunarHoward Hughes Medical Institute, Chevy Chase, Maryland, USA.
Michael G PoulosHoward Hughes Medical Institute, Chevy Chase, Maryland, USA.
Michael GinsbergAngiocrine Bioscience, New York, New York, USA.
Daniel J NolanAngiocrine Bioscience, New York, New York, USA.
Zachary K NorgaardClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Jennifer E AdairClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Shahin RafiiHoward Hughes Medical Institute, Chevy Chase, Maryland, USA.
Hans-Peter KiemClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Fred Hutch Cancer Center · USHoward Hughes Medical Institute · USAngiocrine Bioscience (United States) · USCornell University · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
VECTOR CONSTRUCTIONS FOR GENE THERAPY OF SICKLE CELL DISEASEP01HL053750 · NHLBI · UNIVERSITY OF WASHINGTON · PI RUSSELL, DAVID W · 1994 to 2014
$30.4M
Nonhuman Primate Reagent ResourceU24AI126683 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Diogo Magnani · 2016 to 2026
$20.1M
Training Program in Developmental BiologyT32HD060600 · NICHD · WEILL MEDICAL COLL OF CORNELL UNIV · PI BAO, ZHIRONG, STUHLMANN, HEIDI · 2010 to 2024
$3.5M
Evaluation of Pluripotent Stem Cell-Derived Blood Cells in Nonhuman Primate ModelR01HL115128 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KIEM, HANS-PETER, RAFII, SHAHIN · 2013 to 2016
$3.3M
Cord Blood Expansion/Transplantation Nonhuman PrimateR01HL084345 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KIEM, HANS-PETER · 2006 to 2009
$2.8M
Development of safe and efficient gene therapy strategies for hemoglobinopathiesR01HL098489 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KIEM, HANS-PETER · 2010 to 2013
$2.8M
Howard Hughes Medical InstituteNCI NIH HHS P30 CA015704NHLBI NIH HHS P01 HL053750NHLBI NIH HHS R01 HL084345NHLBI NIH HHS R01 HL098489NHLBI NIH HHS R01 HL115128NIAID NIH HHS U24 AI126683NICHD NIH HHS T32 HD060600
6 · The paper itself

Abstract

Successful expansion of bone marrow (BM) hematopoietic stem and progenitor cells (HSPCs) would benefit many HSPC transplantation and gene therapy/editing applications. However, current expansion technologies have been limited by a loss of multipotency and self-renewal properties ex vivo. We hypothesized that an ex vivo vascular niche would provide prohematopoietic signals to expand HSPCs while maintaining multipotency and self-renewal. To test this hypothesis, BM autologous CD34

Indexed as

Hematopoietic Stem Cell TransplantationAnimalsAntigens, CD34Bone Marrow CellsCell LineageCell ProliferationEndothelial CellsGene Expression ProfilingHematopoiesisHematopoietic Stem CellsHumansPrimatesTime FactorsAntigens, CD34Bone marrow transplantationCD34+ cellsEndothelial cellsGene therapyHematopoietic stem progenitor cell

Identifiers

PMID28297579
PMCPMC5442761
OpenAlexW2530049394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.